Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07651644
Recruiting
Two-component Radiology-guided Autonomous Cascade Engine (TRACE)
Not applicable · China · 1 site
Registry update: 16 Jun 2026
2025-522138-29-00
Recruiting
Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
Phase 2 · Germany, Spain, France, Greece, Hungary, Italy, Netherlands, Poland · 21 sites
Registry update: 31 Aug 2026
NCT07286266
Recruiting
A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
Phase 3 · Australia, Canada, United Kingdom, Japan, South Korea · 17 sites
Registry update: 15 Oct 2026
NCT07554339
Recruiting
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Phase 3 · Argentina, Australia, Brazil, China, Germany, Spain, France, United Kingdom, Greece, Italy, Japan, South Korea, Netherlands, Poland, Taiwan, Ukraine, United States · 127 sites
Registry update: 2 Nov 2026
NCT07588100
Recruiting
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
Phase 1 · United States · 4 sites
Registry update: 13 Oct 2026
NCT07492979
Recruiting
Conduction System Pacing vs. Biventricular Pacing for Cardiac Resynchronization Therapy
Not applicable · Denmark, Finland, Norway, Sweden · 5 sites
Registry update: 28 Jul 2026
NCT07656454
Recruiting
A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants
Phase 1 · Germany · 1 site
Registry update: 30 Jun 2026
Conflicting statuses (not updated in the registry for 4 months)
2026-525543-32-00
Recruiting
A study to investigate how a single dose of the drug melflufen reaches brain tumor tissue, and how it affects the tumour, in patients who are already scheduled for surgery for a returning glioblastoma
Phase 1 · Norway · 1 site
Registry update: 15 May 2026
NCT07581184
Recruiting
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · United States · 8 sites
Registry update: 2 Nov 2026
NCT07012031
Recruiting
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Phase 1/2 · United States · 9 sites
Registry update: 4 Sept 2026
NCT07652970
Recruiting
Tele-CE in Severe Stroke
Not applicable · United States · 1 site
Registry update: 9 Oct 2026
NCT07660731
Recruiting
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Phase 1 · Belgium, United States · 2 sites
Registry update: 3 Nov 2026
NCT07567027
Recruiting
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
Not applicable · United States · 1 site
Registry update: 9 Jul 2026
NCT07363161
Recruiting
BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)
Not applicable · Switzerland, Germany · 3 sites
Registry update: 20 Jul 2026
NCT07781124
Recruiting
Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities
Not applicable · China · 20 sites
Registry update: 24 Aug 2026
NCT07868250
Recruiting
KPSC MNT Pilot RCT
Not applicable · United States · 1 site
Registry update: 9 Oct 2026
NCT07600801
Recruiting
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
Not applicable · United States · 1 site
Registry update: 25 Aug 2026
NCT07913152
Recruiting
Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac Patients
Not applicable · Israel · 1 site
Registry update: 3 Nov 2026
NCT07280715
Recruiting
Investigating Real-Time Immunotherapy Symptoms Study
Not applicable · United States · 1 site
Registry update: 4 Aug 2026
NCT07619820
Recruiting
A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · China · 1 site
Registry update: 7 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.